acetylgalactosamine has been researched along with paclitaxel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, P; Li, T; Meng, X; Sun, B; Yu, P; Zhu, T | 1 |
1 other study(ies) available for acetylgalactosamine and paclitaxel
| Article | Year |
|---|---|
N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
Topics: Acetylgalactosamine; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Molecular Structure; Nanoparticles; Paclitaxel; Structure-Activity Relationship | 2021 |